Chromium(VI) induced alterations in mouse spleen cells: a short-term assay.
Cr(VI), the highest oxidation state for chromium, is a carcinogenic and mutagenic agent. In vivo and in vitro Cr(VI) toxic effects are related to its intracellular fate. Once inside the cell it is reduced to stable Cr(III) by cysteine, glutathione and ascorbic acid. Additionally, as Cr(V) and/or Cr(IV) intermediates have been reported in Cr(VI) reactions with biological reductants, chromium damage is thought to originate from these chemical species. This work investigated the morphology of splenic cells after short-term exposure to Cr(VI). A dose of 30 mg of K2CrO4/kg body weight was administered to mice and the effects were studied 24 and 48 h after the injections. Histological results revealed a time-dependency effect of Cr(VI) on splenic cells. Changes included enlargement of the capsule and depletion of the red pulp cells, accompanied by an increase in macrophages, 24 h after injection. Partial restoration of red pulp was noted after 48 h.
das Neves
R P
RP
Departamento de Biologia, Universidade de Aveiro, Portugal,
Santos
T M
TM
de Pereira
M L
ML
de Jesus
J P
JP
D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D002840:Chromates / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D002857:Chromium / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D008264:Macrophages / Q000187:drug effects; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D017680:Potassium Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D013154:Spleen / Q000033:anatomy & histology / Q000166:cytology / Q000187:drug effects*; D013997:Time Factors
D002273:Carcinogens; D002840:Chromates; D017680:Potassium Compounds; D002857:Chromium; C027373:potassium chromate(VI)